Formulation of nanoparticles loaded in situ gel for treatment of dry eye disease: In vitro, ex vivo and in vivo evidences

Patel, 2013, Ocular drug delivery systems: an overview, World J. Pharmacol., 2, 47, 10.5497/wjp.v2.i2.47 Boddu, 2013, A brief overview of ocular anatomy and physiology, 3 Pascolini, 2012, Global estimates of visual impairment: 2010, Br. J. Ophthalmol., 96, 614, 10.1136/bjophthalmol-2011-300539 Cem Simsek, 2018, Current management and treatment of dry eye disease, Turkish J. Orthod., 48, 309 2017 Lemp, 2007, The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop, Ocul. Surf., 5, 75, 10.1016/S1542-0124(12)70081-2 Survarna, 2015, 1 Brown, 1997 Schaumberg, 2009, Prevalence of dry eye disease among US men: estimates from physicians health study, Arch. Ophthalmol., 127, 763, 10.1001/archophthalmol.2009.103 Pflugfelder, 2008, Prevalence, burden and pharmcoeconomics of dry eye disease, Am. J. Manag. Care, 14, S102 Zhang, 2016, Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics, J. Ophthalmol., 1 Zhang, 2015, Role of peroxisome proliferator-activated receptor γ in ocular diseases, J. Ophthalmol., 1 Chen, 2014, Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice, Mol. Med. Rep., 9, 2015, 10.3892/mmr.2014.2041 Rafati, 2010, Fabrication of biodegradable Poly (d,llactide- co-glycolide) nanoparticles containing tamoxifen citrate, Iran. Polym. J. (Engl. Ed.), 19, 437 Wagh, 2014, Cyclosporine a loaded PLGA nanoparticles for dry eye disease: In vitro characterization studies, Journal of Nanotechnology, 1, 10.1155/2014/683153 Pandit, 2016, Chitosan coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization and in-vitro toxicity evaluation, Artificial cells, Nanomed. Biotechnol., 1 Xiangrong, 2008, Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency, Eur. J. Pharm. Biopharm., 69, 445, 10.1016/j.ejpb.2008.01.013 Bhambere, 2014, Effect of polymer and formulation variables on properties of self-assembled polymeric micellar nanoparticles, J. Nanomed. Biother. Discov., 4, 1, 10.4172/2155-983X.1000129 Upadhay Shivam, 2020, Nanoparticles laden in situ gel for sustained drug release after topical ocular administration, J. Drug Deliv. Sci. Technol., 57, 101736, 10.1016/j.jddst.2020.101736 Barse, 2016, Influence of hydroxypropylmethylcellulose and poloxamer composite on developed ophthalmic in situ gel: ex vivo and in vivo characterization, J. Drug Deliv. Sci. Technol., 66, 10.1016/j.jddst.2016.03.011 Tapia-Guerrero, 2020, Effect of UV and gamma irradiation sterilization processes in the properties of different polymeric nanoparticles for biomedical applications, Materials, 13, 1, 10.3390/ma13051090 Shrividya, 2001, Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system, J. Contr. Release, 75, 205, 10.1016/S0168-3659(01)00279-6 Bhandwalkar, 2013, Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization and pharmacodynamic evaluation, AAPS PhaciTech, 14, 101, 10.1208/s12249-012-9893-1 Balasubramanium, 2003, In vitro and in vivo evaluation of the Gelrite_ gellan gum-based ocular delivery system for indomethacin, Acta Pharm., 53, 251 Rajesh, 2016, Preparation and evaluation of nanoparticle loaded ophthalmic in situ gel, Drug Deliv., 23, 2263 2010, 27 Jain, 2011, Microscopic and spectroscopic evaluation of novel PLGA-chitosan nanoplexes as an ocular delivery systems, Colloids Surf., B, 82, 397, 10.1016/j.colsurfb.2010.09.010 Lin, 2011, A mouse dry eye model induced by topical administration of benzalkonium chloride, Mol. Vis., 17, 257 Dilek, 2002, A mouse model of keratoconjunctivitis sicca, Invest. Ophthalmol. Vis. Sci., 43, 632 Stefano, 2004, 613 Robert, 1984, Sjogren's syndrome in mrl/1 and mrlh mice, Arthritis Rheum., 27, 157, 10.1002/art.1780270206 Danaei, 2018, Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems, Pharmaceutics, 10, 1, 10.3390/pharmaceutics10020057 Tahara, 2010, Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-Lactide-Co-Glycolide) nanospheres for gene delivery, Eur. J. Pharm. Biopharm., 75, 218, 10.1016/j.ejpb.2010.03.013 Aksungur, 2011, Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies, J. Contr. Release, 151, 286, 10.1016/j.jconrel.2011.01.010 Nabil, 2020, Stimulus responsive ocular gentamycin-ferrying chitosan nanoparticles hydrogel: formulation optimization, ocular safety and antibacterial assessment, Int. J. Nanomed., 15, 4717, 10.2147/IJN.S254763 Ameeduzzafar, 2018, Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment, Artificial Cells, Nanomed. Biotechnol., 46, 959